BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31707908)

  • 1. Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies.
    Wang C; Lu N; Chen WC; Li H; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2020 May; 30(3):495-507. PubMed ID: 31707908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data.
    Chen WC; Wang C; Li H; Lu N; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2020 May; 30(3):508-520. PubMed ID: 32370640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies.
    Wang C; Li H; Chen WC; Lu N; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2019; 29(5):731-748. PubMed ID: 31530111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leverage multiple real-world data sources in single-arm medical device clinical studies.
    Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2022 Jan; 32(1):107-123. PubMed ID: 33844621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity score-incorporated adaptive design approaches when incorporating real-world data.
    Lu N; Chen WC; Li H; Song C; Tiwari R; Wang C; Xu Y; Yue LQ
    Pharm Stat; 2024; 23(2):204-218. PubMed ID: 38014753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian Divide-and-Conquer Propensity Score Based Approaches for Leveraging Real World Data in Single Arm Clinical Trials.
    Baron E; Zhu J; Tang RS; Chen MH
    J Biopharm Stat; 2022 Jan; 32(1):75-89. PubMed ID: 35094643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity score-integrated approach to survival analysis: leveraging external evidence in single-arm studies.
    Chen WC; Lu N; Wang C; Li H; Song C; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2022 May; 32(3):400-413. PubMed ID: 35675348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
    Liu M; Bunn V; Hupf B; Lin J; Lin J
    Stat Med; 2021 Sep; 40(22):4794-4808. PubMed ID: 34126656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources.
    Lu N; Wang C; Chen WC; Li H; Song C; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2022 Jan; 32(1):158-169. PubMed ID: 34756158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological considerations when analysing and interpreting real-world data.
    Stürmer T; Wang T; Golightly YM; Keil A; Lund JL; Jonsson Funk M
    Rheumatology (Oxford); 2020 Jan; 59(1):14-25. PubMed ID: 31834408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the performance of propensity score methods in healthcare database studies with rare outcomes.
    Franklin JM; Eddings W; Austin PC; Stuart EA; Schneeweiss S
    Stat Med; 2017 May; 36(12):1946-1963. PubMed ID: 28208229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to augment single-arm clinical studies with real-world data.
    Sachdeva A; Tiwari RC; Guha S
    J Biopharm Stat; 2022 Jan; 32(1):141-157. PubMed ID: 34958629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covariate balance-related propensity score weighting in estimating overall hazard ratio with distributed survival data.
    Huang C; Wei K; Wang C; Yu Y; Qin G
    BMC Med Res Methodol; 2023 Oct; 23(1):233. PubMed ID: 37833641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of diagnostic tests for low prevalence diseases: a statistical approach for leveraging real-world data to accelerate the study.
    Chen WC; Li H; Wang C; Lu N; Song C; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2021 May; 31(3):375-390. PubMed ID: 33615997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical considerations of utilizing propensity score methods in clinical development using real-world and historical data.
    Li Q; Lin J; Chi A; Davies S
    Contemp Clin Trials; 2020 Oct; 97():106123. PubMed ID: 32853779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should a propensity score model be super? The utility of ensemble procedures for causal adjustment.
    Alam S; Moodie EEM; Stephens DA
    Stat Med; 2019 Apr; 38(9):1690-1702. PubMed ID: 30586681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity score analysis with partially observed covariates: How should multiple imputation be used?
    Leyrat C; Seaman SR; White IR; Douglas I; Smeeth L; Kim J; Resche-Rigon M; Carpenter JR; Williamson EJ
    Stat Methods Med Res; 2019 Jan; 28(1):3-19. PubMed ID: 28573919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covariate Balancing through Naturally Occurring Strata.
    Alemi F; ElRafey A; Avramovic I
    Health Serv Res; 2018 Feb; 53(1):273-292. PubMed ID: 27976388
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.